Tool for predicting local recurrence in lung cancer patients identified
December 7th, 2010 - 2:48 pm ICT by ANIWashington, Dec 07 (ANI): Positron emission tomography/computed tomography (PET/CT) scans have been identified as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA).
RFA, which uses localized thermal energy to kill cancer cells, is increasingly used as an alternative treatment for patients unable to undergo surgery or other therapies to treat lung cancer.
“This study reinforces the utility of 18F-FDG-PET imaging in cancer detection and follow-up while also providing new insight into factors that can be used for earlier prediction of recurrence after radiofrequency ablation of lung tumors,” said Amit Singnurkar, FRCPC, assistant professor of radiology and medicine at McMaster University and lead author of the study ‘18F-FDG PET/CT for the Prediction and Detection of Local Recurrence After Radiofrequency Ablation of Malignant Lung Lesions.’
The five-year study followed 68 patients with 94 pulmonary lesions, including metastases and primary lung cancers. By reviewing 18F-FDG PET/CT scans performed before and after RFA, researchers were able to determine several indicators that could help predict local recurrence.
Among pre-RFA scans, lesion size and type of tumor (primary or metastases) were factors in determining potential for local recurrence. Standardized uptake value (glucose metabolic activity) was also a factor in pre-RFA scans, although not independent of lesion size.
PET/CT scans conducted after RFA indicated that 18F-FDG uptake patterns, size of ablation margins and standardized uptake value were parameters that could predict the likelihood of recurrence.
Information gleaned from the pre- and post-PET/CT scans can increase the accuracy of recurrence detection and allow earlier diagnosis. This ultimately can facilitate better management, leading to improved patient outcomes.
“Used correctly, molecular imaging can provide more accurate and earlier results than anatomic imaging alone,” noted Singnurkar.
“Molecular imaging has the potential to detect and characterize disease earlier, at a point where it can be more amenable to therapy,” added Singnurkar.
The study has been published in the December issue of The Journal of Nuclear Medicine. (ANI)
- Radio frequency ablation effectively reduces pain from bone metastases - Jan 05, 2010
- CT scan more effective in parallel breast and bone cancer detection - Sep 06, 2010
- PET-CT scans may help predict response to head, neck cancer treatment - Nov 17, 2009
- Potential new imaging technique 'helps identify malignant breast tumours' - Dec 18, 2009
- MRI can help locate prostate cancer recurrence at extremely low PSA levels - Apr 30, 2011
- Radio-guided op safe, simple way to remove cancerous nodules in lung - Feb 28, 2011
- Cancer diagnosis facility opened in Dubai - Jan 28, 2010
- Dubai opens plant to produce drug for cancer patients - Jan 28, 2010
- Novel technique to track cancer's response to drugs - Jul 28, 2009
- Raman effect makes cancer detection possible - Apr 21, 2011
- Ultrasound as effective as CT scans in most cases - May 12, 2011
- Cysts to reveal pancreatic cancer risk - Jun 04, 2010
- Polymer pill the best method to improve lung cancer diagnosis - Apr 29, 2010
- New technique for liver cancer treatment proves effective - Apr 13, 2008
- 'Silent' brain damage could point to increased stroke risk - Jun 08, 2010
Tags: ablation, better management, cancer cells, cancer detection, fdg pet imaging, fdg uptake, lung cancer patients, lung cancers, lung lesions, lung tumors, mcmaster university, metabolic activity, metastases, molecular imaging, patient outcomes, pet ct scans, positron emission, pulmonary lesions, size pet, thermal energy